UV irradiation has been shown to activate the human immunodeficiency virus type 1 (HIV-1) long terminal repeat (LTR) in cell culture; however, only limited studies have been described in vivo. UV light has been categorized as UV-A (400 to 315 nm), -B (315 to 280 nm), or -C (<280 nm); the longer wavelengths are less harmful but more penetrative. Highly penetrative UV-A radiation constitutes the vast majority of UV sunlight reaching the earth's surface but is normally harmless. UV-B irradiation is more harmful but less prevalent than UV-A. In this report, the HIV-1 LTR-luciferase gene in the skin of transgenic mice was markedly activated when exposed to UV-B irradiation. The LTR in the skin of transgenic mice pretreated topically with a photosensitizing agent (psoralen) was also activated to similar levels when exposed to UV-A light. A 2-h exposure to sunlight activated the LTR in skin treated with psoralen, whereas the LTR in skin not treated with psoralen was activated after 7 h of sunlight exposure. The HIV-1 LTR-p-galactosidase reporter gene was preferentially activated by UV-B irradiation in a small population of epidermal cells. The transgenic mouse models carrying HIV-1 LTR-luciferase and LTR-,I-galactosidase reporter genes have been used to demonstrate the in vivo UV-induced activation of the LTR and might be used to evaluate other environmental factors or pharmacologic substances that might potentially activate the HIV-1 LTR in vivo.
preferentially activated by UV-B irradiation in a small population of epidermal cells. The transgenic mouse models carrying HIV-1 LTR-luciferase and LTR-,I-galactosidase reporter genes have been used to demonstrate the in vivo UV-induced activation of the LTR and might be used to evaluate other environmental factors or pharmacologic substances that might potentially activate the HIV-1 LTR in vivo.
In this report, an environmental factor, UV light, was evaluated for its ability to activate the human immunodeficiency virus type 1 (HIV-1) long terminal repeat (LTR) in transgenic mice. Factors that activate the dormant HIV genome are important areas of study, since the activated provirus may contribute to disease progression (39) . Potentially latent virus is found in cells having the CD4 surface marker, which includes T-helper cells, macrophages, and their differentiated lineages, namely, Langerhans cells located in the skin (49, 52) . It is has been proposed that HIV-1 in Langerhans cells might be induced by activation factors. Certain viral protein interactions with the HIV-1 LTR (10), antigenic stimulation (12, 44) , and cellular differentiation factors (28) are considered to be important for the activation of the virus.
UV light has been categorized as UV-A (400 to 315 nm), -B (315 to 280 nm), or -C (<280 nm); the longer wavelengths are less harmful but more penetrative. Consequently, highly penetrative UV-A radiation constitutes the vast majority of UV sunlight reaching the earth's surface but is normally harmless; and UV-B irradiation is more harmful but less prevalent. UV-B and -C irradiation in cell culture experiments has been shown to induce the HIV-1 LTR regulating the expression of the chloramphenicol acetyltransferase reporter gene (46, 47, 53) and the infectious virus (45, 53) . In cell culture, UV-A irradiation has been shown to activate the LTR, but only if cells are pretreated with a photosensitizing agent (54, 56) . This observation merits further investigation in vivo since chemically induced phototoxicity is not uncom-* Corresponding author. mon (9, 11, 50) . When certain photosensitizing chemicals are present in the skin as administered topically or systemically, phototoxic effects of normally harmless UV-A irradiation greatly increase, probably by similar DNA-damaging mechanisms as those induced by UV-B (11). These chemicals include psoralen, used to treat vitiligo and psoriasis (50) , naturally occurring psoralens found in some foods (1, 9) , organic substances used for industrial applications (11) , and some commonly used antibiotics (3) .
In this study, UV-B irradiation and UV-A irradiation in combination with a photosensitizing chemical (psoralen) were shown to activate the HIV-1 LTR in the skin of transgenic mice. The LTR was preferentially activated by UV-B irradiation in a small population of epidermal cells.
MATERIALS AND METHODS
Transgenic mice. Purified linearized HIV-1 LTR expression vectors were microinjected into pronuclei of fertilized FVB/N mouse embryos (28) , and the embryos were implanted into CD-1 foster mice (20) . The resulting progeny were screened for transgenic DNA by polymerase chain reaction (42) and luciferase and P-galactosidase assays. The luciferase gene was described previously (7) , and the HIV-1 LTR used (strain HXB2 [40] ) for the firefly luciferase construct contained sequences -167 to +80. The HIV-1 LTR with the P-galactosidase gene was con- trols.
In the first described experiment, the skin of four mice was exposed to 1,000, 667, 333, or 0 J of UV-B light per mi2. Four other mice were treated topically with psoralen and exposed to 30,000, 20,000, 10,000, or 0 J of UV-A light per M2. The next day, 6-mm-diameter skin biopsy specimens were obtained from each section and processed for luciferase activity. Values from tissues of nontransgenic mice were <250 RLU.
In the experiment to determine the dependence on psoralen of UV-A-induced activation of the LTR, no background biopsies were done the day the mice were irradiated. All six mice were derived from the same founder mouse.
To determine minimal effective dosages, the abdomen of each mouse, derived from the same founder transgenic mouse, was divided into five sections which were exposed to graded dosages of UV-A light plus psoralen or UV-B light. The next day, luciferase activity was determined in biopsy specimens taken from each section. Duplicate samples from each section of six and four mice for UV-A and UV-B exposures, respectively, were assayed. One-way analysis of variance was used to determine statistical significance.
Sunlight exposure. Sections of skin on the backs of four progeny transgenic mice were treated with psoralen and then exposed to 2 h of direct sunlight, exposed to sunlight without psoralen, or not exposed. Exposure was at 4,500 feet of elevation from 11 a.m. to 1 p.m. In a separate experiment, sections of skin not treated with psoralen on the backs of four progeny transgenic mice were exposed to 7 h of sunlight or not exposed. They were exposed for 4 h the first day and 3 h the second day and assayed on the third day, 1 day after the final exposure.
RESULTS
To evaluate the biological effects of UV radiation in vivo, we constructed transgenic mice to contain the HIV-1 LTR linked to either the firefly luciferase or the ,-galactosidase reporter gene. Mice were irradiated with various dosages of UV-B light after being shaved and depilated. Those exposed to UV-A irradiation were also pretreated with the photosensitizing agent psoralen. The next day, activation of the HIV-1 LTR was quantitated by determining the luciferase activity in homogenized skin tissue. The anatomical location of cells expressing the reporter gene was identified by in situ staining of P-galactosidase activity in histological skin sections.
UV-A irradiation activated the LTR in the skin of mice pretreated topically with psoralen ( Table 1 ). The LTR activation was dose responsive; the greatest dosage tested (30,000 J/m2) increased the reporter gene activity a maximum 2,000-fold (2 to 3 log1o) above background. The luciferase activity was increased to a lesser extent, being 1 to 2 loglo above background in the skin of mice exposed to the two lower UV dosages tested (10,000 and 20,000 J/m2). The UV-A-induced activation depended on the presence of psoralen (Table 2) , because psoralen without UV-A exposure or psoralen administered after UV-A exposure could not activate the LTR above background levels, whereas treatment with psoralen followed by UV-A irradiation markedly activated the LTR.
The reporter gene activity was activated 2 to 3 log1o above background when the mice were irradiated with 333 J of UV-B light per m2 ( Table 1 ). The LTR activity was greatest with a UV-B dosage of 333 J/m2 and decreased with greater exposure dosages. To determine whether the UV-induced LTR activation was due to direct alteration of the enzymatic properties of luciferase, we diluted molecularly cloned luciferase (Sigma) in the reaction buffer at sufficient quantities to achieve about 7 x 105 RLU, whereas reaction buffer alone produced about 250 RLU. A volume of 0.5 ml was dispensed into wells of a 24-well tissue culture plate, and the samples were irradiated with UV-B at dosages of 0, 333, 667, and 1,000 J/m2 with the cover of the tissue culture plate removed. Molecularly cloned luciferase did not exhibit increased activity as a result of UV irradiation; therefore, the increased activity observed in the transgenic mice was probably due to an increased production of luciferase in cells. Moreover, UV-induced activation was also observed with transgenic mice carrying the 13-galactosidase reporter gene ( Fig. 1) , demonstrating that the effect was not luciferase specific. Negative controls in Table 1 consisted of biopsy specimens obtained from shaved areas not exposed to UV light. Biopsy specimens were obtained immediately before UV exposure (background) and 24 h later at the time of nec- Mice were prepared for UV irradiation as described in Table 1 , footnote a, except that no preexposure biopsies were done. Tissues were then processed for in situ f3-galactosidase activity. (A) Unexposed, x 100; (B) UV-B exposed, x 100; and (C) UV-B exposed, x400.
dose, for lightly pigmented Caucasian skin is 2 x 105 J/m2 between 330 and 400 nm (without psoralen pretreatment) and 200 J/m2 for wavelengths between 250 and 300 nm (35) . It appeared by comparing the minimal LTR dosages with the minimal erythema doses that minor sunlight exposure might activate the LTR in the skin. The possible clinical relevance of UV induction was investigated by exposing the shaved backs of transgenic mice to direct sunlight for 2 h. A portion of skin without psoralen treatment and a portion with psoralen treatment were used. The HIV-1 LTR was not significantly activated above control background levels in the sun-exposed skin not treated with psoralen, whereas the levels of luciferase in the skin pretreated with psoralen and exposed to 2 h of sunlight were activated about 20-fold above background levels (P < 0.01) when assayed 24 h postexposure (Table 4) . To identify time of sunlight exposure that could activate the LTR in skin not treated with psoralen, we exposed mice to a total of 7 h of sunlight. At this time, the luciferase levels were increased 17-to 643-fold above the values in unexposed skin (Table 4) .
To determine the location of skin cells expressing increased levels of reporter gene activity induced by UV irradiation, shaved skin of founder transgenic mice carrying 1A ). In UV-exposed skin sections, however, there were markedly increased numbers of cells expressing the reporter gene that were located in the epidermis (Fig. 1B and C) .
DISCUSSION
With the use of the HIV-1 LTR-luciferase and LTR-pgalactosidase reporter genes, the quantitative level and anatomical site of UV-induced activation of the HIV-1 LTR were determined in the skin of transgenic mice. In this report, the HIV-1 LTR-luciferase gene in the skin was activated a maximum of 1,000-to 2,000-fold above background levels when exposed to either UV-B irradiation or UV-A irradiation in combination with a photosensitizing agent, psoralen. This perceived induction as determined by the luciferase reporter gene activity may, or may not, reflect the actual induction of the LTR, because the turnover rate of the protein or its mRNA is not known in the skin of these animals. Also, the UV-induced activation of the LTR is somewhat variable for mice of a given transgenic line. The answer to or the biological significance of this variability is not currently known and is under investigation.
Other investigators have determined that UV-A irradiation did not activate the HIV-1 LTR in vitro, but psoralen or photosensitizing agents were not used (45) (46) (47) 53) . However, in one recently published study (54) and in a study described as unpublished data (56), UV-A irradiation did activate the LTR when cells were treated with psoralen. In agreement with these cell culture studies, UV-A-induced activation of HIV-1 LTR in the skin of transgenic mice was dependent on pretreatment with a photosensitizing agent. This activation may be specific to the DNA-damaging effects of photosensitizing agents plus long wavelengths of UV light and is probably not a general cytotoxic phenomenon.
Some pharmacological substances are known to be photosensitizing agents (3). This may be particularly relevant since the treatment of opportunistic infections is a major consideration for AIDS patients and involves the chronic use of potentially numerous therapeutic substances. If chemically induced photosensitizing reactions were to occur, HIV could conceivably be induced.
Association of HIV infection in people with photosensitivity has been noted on rare occasions (6, 21, 22, 51) . These reports, coupled with the findings of this study, suggest that photosensitivity of HIV-infected people should be investigated further.
Tissue-specific expression of HIV-1-LTR chloramphenicol acetyltransferase has previously been described (28) (Fig. 1) . The UV-induced LTR-activated epidermal cells of this study, therefore, might be either the Langerhans cells or another skin dendritic cell of possibly T-cell origin, the Thy-l-positive dendritic cells (27, 48) . Since Langerhans cells in the skin of HIV-1-infected people have been shown to be infected with HIV, these skin cells when subjected to UV irradiation may serve as an increased reservoir of virus production. This infection could selectively impair the antigen presentation function of the infected Langerhans cells and cause further immunosuppression, and it might result in increased infection of the adjacent T-cell compartment of the skin (49) . This HIV effect with skin cells may have implications for progression of AIDS-associated skin lesions such as Kaposi's sarcoma (55) .
The UV-induced HIV-1 LTR-p-galactosidase expression of one of the three founder transgenic mice of this study was similar to the activation observed previously in transgenic mice carrying ,-galactosidase (5) . Essentially all the epidermal cells at the surface of the skin exposed to UV-B light expressed the transgene (data not shown). The UV-irradiated skin of the other two founder mice shown in this study (Fig. 1) preferentially expressed the UV-induced activated transgene in only a small population of epidermal cells, and no P-galactosidase activity was detected in the vast majority of other cells. It is possible, then, that the two mice shown in this study were relatively low expressers of the transgene, such that the P-galactosidase activity was not detectable except in a small population of skin cells that preferentially expressed the transgene when exposed to UV light. The ,B-galactosidase activity of high-expressing founder mice might be detectable in essentially all epidermal cells, which might mask those cells that preferentially express the transgene. Progeny mice derived from the low-expressing founder mice of this study might be particularly useful in determining the identity of preferentially activated cells, since reporter gene activity was not detected in all epidermal cells.
Another implication of natural UV exposure of HIV-1-infected epidermal cells is that UV irradiation can cause activation of tat-defective HIV provirus as observed in cell culture (41) . With UV-induced activation, the defective virus may undergo replication without functional tat. With sufficient rounds of replication, the tat gene may revert to wild type owing to the high mutation rate of the virus, thereby rescuing a wild-type virus. This UV-induced effect, then, may play a role in rescuing defective virus that possibly exists in the cells of HIV-infected people (31) .
The minimal dosage of psoralen-dependent UV-A and UV-B irradiation required for the activation of HIV-1 LTRluciferase reporter gene was sufficiently low to suggest that sunlight exposure commonly encountered by people activates the LTR (35) . Furthermore, the radiometer used in these studies was pointed toward the sun to calculate that 1.9
x 104 J of UV-A per m2 and 1.2 x 103 J of UV-B per M2 would be obtained during a 2-h exposure. Even though direct comparisons of these sunlight values cannot be made accurately with the values generated from UV lamps, the sunlight values were sufficiently greater than the minimum experimental -dosages required to activate the LTR ( Table 3) that one might expect the LTR to be activated by sunlight. In a test of this hypothesis, the LTR in the skin not treated with psoralen was activated by sunlight when assayed at 7 h. Because the sun-exposed and mock-exposed treatments were done on the back of the same mouse, with four mice used as replicates, the effect of whole-body stress was removed from the analysis. These data suggest that UVinduced activation of HIV-1 LTR is a clinical possibility and that people exposed to photosensitizing agents increase their risk of virus activation compared with people not exposed to photosensitizing agents and to sunlight.
UV irradiation (46, 47) , heat shock induction, or chemical inducers of cellular stress (15) cause increased expression levels of HIV-1 in mammalian cells in culture. It has been determined that UV-induced gene expression is preceded by absorption of UV light by DNA, which results in DNA damage (47) . This UV-induced DNA damage causes new synthesis of a large number of specific gene products (13) , which is similar to the response, named SOS, that occurs in bacteria (38) . One possible mode of activation involves initial induction of the c-fos gene (56) . The c-fos gene is activated very rapidly following UV exposure and other stressor-specific steps (23) . Activation of c-fos is important for induction of the HIV promoter (19, 43) and may signal activation of the LTR by the fos protein affecting activation of NF-KB protein. Supporting this concept is the observation that UV irradiation induces a factor, which can be detected extracellularly, that subsequently induces HIV-1 transcription in other cells (46) . This factor-dependent HIV-1 transcription requires the major HIV-1 enhancer (47), termed NF-KB-binding site (32) .
The NF-KB-binding sites are also the responsive elements for the induction of the HIV-1 LTR by some cytokines such as tumor necrosis factor alpha (8, 16, 34, 37) , interleukin-1 (25, 34) , and interleukin-6 (29, 36 
